Recent Articles

April 17, 2015 3:30 pm
Ryan Bushey, Associate Editor
One of the main sessions at this year’s Experimental Biology Conference in Boston was the Tang Prize Award lecture. Read more...
April 17, 2015 10:23 am
Magnus Jansson, Ph.D., CSO, SymCel Sverige AB
New, innovative technology solves challenges in antibiotic resistance and the drug development cycle. Read more...
April 16, 2015 10:40 am
Suzanne K. Minton, Ph.D., Scientific Content Specialist, Certara
Monoclonal antibodies (mAbs) are large Y-shaped proteins that are produced by immune cells to defend the body against pathogens. A hallmark of antibodies is their ability to specifically bind to epitopes, or the parts of the antigen that the immune system recognizes, on their molecular targets, which has been harnessed by drug companies to develop treatments for certain cancers and autoimmune diseases. Read more...
April 15, 2015 3:09 pm
Fenix Leung, DPhil, GlobalData’s Oncology and Hematology Analyst
The global treatment market for melanoma will expand more than fourfold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by 2023. Read more...
April 14, 2015 1:50 pm
Nikhilesh Sanyal, Ph.D., GlobalData's Immunology Analyst
GlobalData’s latest report states that this growth will occur across six major markets. Read more...
April 14, 2015 8:49 am
Ryan Bushey, Associate Editor
Shortcomings in the fast-evolving digital health care arena are becoming obvious. Read more...
April 13, 2015 3:47 pm
Drug Discovery & Development Staff
Coffee drinking is often associated with lower rates of degenerative diseases, from Parkinson’s to cancers. Two recent studies support one theory why: coffee protects DNA from breaking, and quite shortly after it is consumed.
April 13, 2015 1:20 pm
Ryan Bushey, Associate Editor
Investors and financial analysts are worried about this decision. Read more...
April 9, 2015 12:07 pm
Cynthia Fox, Science Writer
The first personalized cancer vaccine using genomics to define targets elicits robust immune responses, says a recent Science study. Read more...
April 7, 2015 5:17 pm
Cynthia Fox, Science Editor
Two recent studies have concluded that tau, not amyloid, is the main driver behind Alzheimer’s disease (AD). Read more...
Subscribe to Drug Discovery & Development